Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Volume is picking up, and I hope it will spark some interest.
Assuming the volume will be over 5 million today, it looks like the 3-day volume average will be over 5 million since late October. Volume precedes price.
The strategy here is to hold our stock. Simple. The shorts still need our shares badly, and not only aren’t AMC shareholders selling, they (we) are actually accumulating more! The daily price swings are irrelevant. It’s the end game that keeps investors here. Most know that eventually the markets will hit a bump, crash, or plummet. This is when anyone short on AMC will get margin called and likely liquidated. Many a short will burn on that Day of Reckoning. It’s soon now, and I’m content to chill and wait for it.
I am waiting on Albright to post his decision to the docket for tMob/Ver, which will hopefully come with a trial date confirmation. VP's last PR stated that they were "anxiously awaiting confirmation." I'm betting we see it this week.
If you bought just above $8 thinking that the Blarcamesine results were published today, relax, you got a bargain. Conservatively, AVXL is worth $24 right now before any further news or clarifications from the company.
Short interest up to another 6 million shares. Now there are 155 million. More guaranteed buys.
I see the value in the Kraig Biocraft Lab. I will keep buying all the shares I can. The field had precious metals, rubies, and gems. KBLB is one of those fields.
I still believe that another squeeze could happen in the near term with the right buying pressure.
Hopefully, Lebby can deliver on what he has been promising for a while now. Until there is nothing else to do, sit it out! Come on, Lebby, deliver us these promised deals and make them ubiquitous!
Slow and steady climb back.
Should be trading at $5–7 fair value based on assets, no debt, and spin-off dividends to shareholders.
It is going to take time to regain investor confidence, but this steady climb back to $1 is a start.
Low float and volume could pop fast.
Not being negative in any way. Until management executes anything they are building out or actions they have expressed, the stock price will be locked in this jail. Management holds the key. Why would MM take the boot off our throats now? There is no reason whatsoever to let it move. They will continue this Groundhog Day scenario until action is shown. Gold could be $3,000, and it will still be at this price. Charts don’t matter either when you are the one holding the paintbrush. The acquisition of another mine won’t mean a thing to the stock price either. It will only be an actionable event that will change it. It’s all up to management at this point. Now, when they do the actionable event, I see some move immediately.
It always dips before the squeeze! Look at the history. Apes strong, Apes resilient. You truly are not prepared for what's about to happen.
Dr Lebby on Benzinga yesterday was very encouraging. Maybe I see things in a different light than I did before. My major concern has been the silence. She was very well spoken and still very upbeat. I believe Lebby is very honest and sincere. Maybe this is the future!!
Debt will be reduced soon, and you will see a big run on AMC. target price is $20 per share.
Looking at the actual numbers of ELTP, the "bear" makes no sense, or probably even cents on any stock the "bear" owns, but it sure gets the "bear" attention. Bullish on ELTP Holding ELTP since 2014 and buying more dips! I strongly believe the company is positioned for big growth going forward. The numbers and actions speak for themselves. If you haven't checked out the last two conference calls and the SEC filings for Quarters 1 and 2 for FY 24,
We have at least a few months before the IDE is submitted. Load up and put your limit in; we‘ll see mid-4s if not today, then next week.
Up from here, dudes. Chart and beginning of revenue for multiple billion-dollar markets There is no need for negativity. 2024 has been the year all along for the reveal. Follow Lebby instead of the doubters and pouters.
Its going to happen in days! Just another week of naked shorting—no big deal! Beyonce is going to be outstanding. Taylor Swift is going overseas on December 13. If any retailer has the slightest doubt, get it out of your melon. You are going to be filthy rich soon. Also note that a large institution has a huge stake in Evergrande, and they don't lose; they have been waiting on the epic squeeze as well.
Small drops, then sweeps upwards. It looks like a nice accumulation is going on. Good sign, Imo!
So what's the plan? They are just going to let this keep getting shorted into the ground without any plan to combat this abuse of the stock? How can they just sit there and do nothing or give no indication they are doing anything to fight this?
On its way to a new 52-week low. I admire the people who can stay positive about this one. Investors are in pain day in and day out since the 20 dollars two years ago. Lebby is busy shining and not bringing in substantial deals. 2 more licensing agreements, as promised by him before year-end. It's time for him to deliver!
It is more bullish than ever. Market makers that are short of this stock will need to cover it when the MTD is denied. One way or another, Citadel is going to be a major funder of dozens of DCVax Direct trials and play an inadvertent role in curing cancer.
Holding this stock is the definition of pain. Every day, it hurts to see this bleeding. Going nowhere until finally some serious revenue news!
Dexcel could prove to be a sleeping giant for Elite. They are the biggest private pharmaceutical company in Israel, but they also distribute products to almost 40 countries.
Nothing in today's CC changes the fact that Rett and Alzheimer are moving towards approval. The delay in the Rett was due to a CRO being late on data safety submission. It is still the same company, with late-stage RETT and Alzheimer moving towards approval and the same drug, A2-73 Blarcamesine, that has never failed a trial, and there have been multiple trials on both Rett and Alzheimer. Nothing has changed other than waiting on one of the Rett CROs. The drop in SP was an overreaction because nothing changed the value of the company. The stock market does not operate on logic for the most part.
$40 million in assets with no debt and a $12 million market cap
Spin off Dmint's $30 million valuation.
Total assets plus Dmint's $70 million are trading at $12 million right now.
Fair value: $5
undervalued
Let this sink in. 47% of $250,000,000 is $117,000,000 directly to AMC! This doesn’t even include concessions or merchandise. It also doesn’t include the next few weeks, and Swift is going into China in December. AMC Distribution is going to bring this company into uncharted territory. This is the most undervalued stock in the market.
And after all that, CitiBank moved an entire, unsponsored AMC float to the Brazilian stock exchange, and now that float is being hidden somewhere offshore, but now they have to come up with it when there's only 198 million shares in the float.
Under .03? Wow, we need some life. Kim, please come through; this was or is my lottery play. I still believe it is hard to keep buying when I invested so much and the price is just constantly slipping. We need some sales to put a fire under this.
Reversal ?? I’ll stick to my prediction this week, I suppose. 015 EOW
As of now, $5.7 million is available to borrow. Let's see what it is in the morning. I've said that when we wake up to 10 million, that's the day I believe things will boom. With the massive calls and puts in the billions expiring today, expect nothing less than fireworks.
EU AD Approval = $20-40B; the odds of this approval sound like better than 75%, and this will likely occur within a year. This should be trading at $20–30.
A little shake and bake to $1+
Wow - a nice and pleasant surprise to start the week. Smart for them to look for approval in Europe first.
FDA cannot drag its feet if AVXL gets EMA approval.
Americans will be rushing to Europe for treatment first.
What is the FDA going to do then?
Best quarter ever; all of the FUD amounts to BS as usual. The lowest price ever, more or less. It’s humorous that the media and spam accounts even try to spin this as anything other than what it is.
I don’t believe NWBO would have gotten favorable terms on a business loan without revealing some serious revenue-generating plans in the works. I would love to see some 8Ks announcing plans that support what I believe loan officers have seen.
I really don’t understand why a well-run, extremely profitable, cutting-edge company with amazing financial statements that dominates a dynamic growth industry cannot show an increase in share price.
It looks like we are going into the Q4 earnings call without RETT and without AD peer review. I would expect a PR tomorrow if we are expecting the earnings call next week. There are only a few weeks left in the year. If the earnings call is delayed until after Thanksgiving, then I think we may get something before earnings. We are witnessing silence from the company, which tells me they are in a critical period for the company, both on the NDA front and in partnership talks. Silence is golden. Hang in there. Our time is coming very soon.
The hedge fund is controlling this for sure. Lebby needs to step up and get this going. We need one good contract with Global Foundary, and all worries are gone. We had enough time to get at least one contract going while we were getting ready for the Santa Claus rally. Let’s go!!!!!!
NWBO really has to come through with the PR by the EOM. They will take a big hit on SP if they don't. The reputation of this company and the MGMT team is at stake. Linda Powers will deliver IMOP, and we will begin our wonderful journey. Timing is everything!